<i>ASXL1</i> mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera
Paola Guglielmelli, Giacomo Coltro, Francesco Mannelli, Giada Rotunno, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Chiara Maccari, Chiara Paoli, Simone Romagnoli, Niccolò Bartalucci, Alessandro M. Vannucchi
Abstract
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera
Topics & Concepts
Essential thrombocythemiaPolycythemia veraInternal medicineMedicineMyelofibrosisOncologyMutationGastroenterologyGeneticsBiologyGeneBone marrowMyeloproliferative Neoplasms: Diagnosis and TreatmentEosinophilic Disorders and SyndromesAcute Myeloid Leukemia Research